Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03381950Active Not Recruiting

Chronic Kidney Disease - Renal Epidemiology and Information Network

Role: collaborator

NCT02212522Unknown

Genetic and Environmental Risk Factors of Type 1 Autoimmune Diabetes and Its Early Complications

Role: collaborator

NCT02425410Unknown

Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset

Role: collaborator

NCT00799565Not ApplicableCompleted

Mitral Valve Prolapse (MVP) - France Study

Role: collaborator

All 4 trials loaded